Novartis Investigative Site

Thessaloniki, Greece GR 546 39

0 studies enrolling now · 3 studies all time

What they study most

Carcinoma, Cardiovascular Disease, Hypertension, Type 2 Diabetes Mellitus

Studies at this site

• Global Study Looking at the Combination of RAD001 Plus Best Supportive Care (BSC) and Placebo Plus BSC to Treat Patients With Advanced Hepatocellular Carcinoma. — Completed
• Study of the Safety and Efficacy of LCZ696 on Arterial Stiffness in Elderly Patients With Hypertension — Completed
• Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints (Core and Extension Phases) — Stopped early